J-Lex

Twimmig tablets 500mg

Twimmig tablets 500mg (YJ_code: 3969026F1027, standard: 500mg x 1 tablet) from Sumitomo Pharma contains imeglimin hydrochloride, a first-in-class oral agent (glimine) for type 2 diabetes. Its unique mechanism targets mitochondrial function to improve glucose-stimulated insulin secretion and enhance insulin action.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).

More from this manufacturer